Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
28 hedge funds and large institutions have $7.24M invested in Entasis Therapeutics Holdings Inc. in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 8 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
3% less funds holding
Funds holding: 29 → 28 (-1)
36% less capital invested
Capital invested by funds: $11.3M → $7.24M (-$4.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$177K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$151K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$95.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.1K |
| 5 |
Renaissance Technologies
New York
|
+$29.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$234K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$217K |
| 3 |
Two Sigma Advisers
New York
|
-$163K |
| 4 |
Jane Street
New York
|
-$107K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$71K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$107K | -32,177 | Closed |
|
|
SFI
27
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$71K | -21,394 | Closed |
|
|
JIP
28
Jaffetilchin Investment Partners
Tampa,
Florida
| – | -$37K | -11,000 | Closed |
|
29
UBS Group
Zurich,
Switzerland
| – | -$18K | -5,310 | Closed |
|
30
Osaic Holdings
Scottsdale,
Arizona
| – | -$7K | -2,100 | Closed |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | -1,000 | Closed |
|
32
Fidelity Investments
Boston,
Massachusetts
| – | -$1.08K | -400 | Closed |
|
33
Morgan Stanley
New York
| – | +$3 | +1 | New |
|
|
AWA
34
Amplius Wealth Advisors
Blue Bell,
Pennsylvania
| – | +$5 | +2 | New |
|
35
Bank of America
Charlotte,
North Carolina
| – | +$49 | +18 | New |
|
ETTX Hedge Fund Activity: Q4 2021 in Review
28 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q4 2021, worth a combined $7.24M — down 36% from $11.3M a quarter earlier.
Fund positioning in ETTX was balanced in Q4 2021: 8 funds opened new positions, 8 closed out, 9 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $177K. The largest seller was Two Sigma Investments, cutting an estimated $234K.
- 28 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q4 2021, down from 29 in Q3 2021.
- Funds reported $7.24M of Entasis Therapeutics Holdings Inc. stock for Q4 2021, down 36% quarter-over-quarter.
- 8 funds opened new Entasis Therapeutics Holdings Inc. positions in Q4 2021 and 8 closed out, a net change of 0 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q4 2021 was Susquehanna International Group, an estimated $177K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q4 2021 was Two Sigma Investments, an estimated $234K sold.
Based on aggregated 13F filings for Q4 2021.